A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Clinical trial NCT06613698 · RECRUITING

Trial details

NCT number: NCT06613698
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Diseases, Alcoholic

Start date: 2024-09-27
Primary completion: 2027-11-26
Enrollment: 393

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.